Tang LSY, Covert E, Wilson E, Kottilil S. Persistent Hepatitis B an infection: A overview. JAMA. 2018;319:1802–13.
Google Scholar
Gill US, Bertoletti A. Medical trial design for immune-based Remedy of Hepatitis B virus. Semin Liver Dis. 2017;37:85–94.
Google Scholar
Li TY, Yang Y, Zhou G, Tu ZK. Immune suppression in power hepatitis B an infection related liver illness: A overview. World J Gastroenterol. 2019;25:3527–37.
Google Scholar
Novak N, Koch S, Allam JP, Bieber T. Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis. J Allergy Clin Immunol. 2010;125:50–59.
Google Scholar
Yonejima A, Mizukoshi E, Tamai T, Nakagawa H, Kitahara M, Yamashita T, et al. Traits of impaired dendritic cell perform in sufferers with Hepatitis B virus an infection. Hepatology. 2019;70:25–39.
Google Scholar
Li M, Zhou ZH, Solar XH, Zhang X, Zhu XJ, Jin SG, et al. Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a potential mechanism of hepatitis B virus persistence. Lab Make investments. 2016;96:1156–64.
Google Scholar
Fisicaro P, Barili V, Rossi M, Montali I, Vecchi A, Acerbi G, et al. Pathogenetic mechanisms of T cell dysfunction in power HBV an infection and associated therapeutic approaches. Entrance Immunol. 2020;11:849.
Google Scholar
Man Okay, Gabriel SS, Liao Y, Gloury R, Preston S, Henstridge DC, et al. Transcription Issue IRF4 promotes CD8(+) T cell exhaustion and limits the event of memory-like T cells throughout power an infection. Immunity. 2017;47:1129–41.
Google Scholar
Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, Wurbel MA, et al. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 1998;17:5334–48.
Google Scholar
Hiltbold EM, Poloso NJ, Roche PA. MHC class II-peptide complexes and APC lipid rafts accumulate on the immunological synapse. J Immunol. 2003;170:1329–38.
Google Scholar
Qin WH, Yang ZS, Li M, Chen Y, Zhao XF, Qin YY, et al. Excessive serum ranges of ldl cholesterol enhance antitumor capabilities of nature killer cells and cut back development of liver tumors in mice. Gastroenterology. 2020;158:1713–27.
Google Scholar
Luo J, Yang H, Tune BL. Mechanisms and regulation of ldl cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21:225–45.
Google Scholar
Schmidt NM, Wing PAC, Diniz MO, Pallett LJ, Swadling L, Harris JM, et al. Focusing on human Acyl-CoA:ldl cholesterol acyltransferase as a twin viral and T cell metabolic checkpoint. Nat Commun. 2021;12:2814.
Google Scholar
Yang W, Bai Y, Xiong Y, Zhang J, Chen S, Zheng X, et al. Potentiating the antitumour response of CD8(+) T cells by modulating ldl cholesterol metabolism. Nature. 2016;531:651–5.
Google Scholar
O’Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage perform. J Exp Med. 2016;213:15–23.
Google Scholar
Norata GD, Caligiuri G, Chavakis T, Matarese G, Netea MG, Nicoletti A, et al. The mobile and molecular foundation of translational immunometabolism. Immunity. 2015;43:421–34.
Google Scholar
Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by ldl cholesterol crystals. Nature. 2010;464:1357–61.
Google Scholar
Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, et al. Decreased atherosclerosis in MyD88-null mice hyperlinks elevated serum levels of cholesterol to activation of innate immunity signaling pathways. Nat Med. 2004;10:416–21.
Google Scholar
Anderson HA, Hiltbold EM, Roche PA. Focus of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol. 2000;1:156–62.
Google Scholar
Eren E, Yates J, Cwynarski Okay, Preston S, Dong R, Germain C, et al. Location of main histocompatibility advanced class II molecules in rafts on dendritic cells enhances the effectivity of T-cell activation and proliferation. Scand J Immunol. 2006;63:7–16.
Google Scholar
Ito A, Hong C, Oka Okay, Salazar JV, Diehl C, Witztum JL, et al. Ldl cholesterol accumulation in CD11c(+) immune cells is a causal and targetable consider autoimmune illness. Immunity. 2016;45:1311–26.
Google Scholar
Westerterp M, Gautier EL, Ganda A, Molusky MM, Wang W, Fotakis P, et al. Ldl cholesterol accumulation in dendritic cells hyperlinks the inflammasome to acquired immunity. Cell Metab. 2017;25:1294–304.
Google Scholar
Bonacina F, Coe D, Wang G, Longhi MP, Baragetti A, Moregola A, et al. Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation. Nat Commun. 2018;9:3083.
Google Scholar
Zhao HJ, Han QJ, Wang G, Lin A, Xu DQ, Wang YQ, et al. Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV by way of era of HBV-specific CD8(+) effector reminiscence T cells. Intestine. 2019;68:2032–43.
Google Scholar
Bian Y, Zhang Z, Solar Z, Zhao J, Zhu D, Wang Y, et al. Vaccines focusing on preS1 area overcome immune tolerance in hepatitis B virus service mice. Hepatology. 2017;66:1067–82.
Google Scholar
Zhao H, Wang H, Hu Y, Xu D, Yin C, Han Q, et al. Chitosan nanovaccines as environment friendly service adjuvant system for IL-12 with enhanced safety in opposition to HBV. Int J Nanomed. 2021;16:4913–28.
Tsimikas S, Gordts P, Nora C, Yeang C, Witztum JL. Statin remedy will increase lipoprotein(a) ranges. Eur Coronary heart J. 2020;41:2275–84.
Google Scholar
Schonewille M, de Boer JF, Mele L, Wolters H, Bloks VW, Wolters JC, et al. Statins enhance hepatic ldl cholesterol synthesis and stimulate fecal ldl cholesterol elimination in mice. J Lipid Res. 2016;57:1455–64.
Google Scholar
van der Kant R, Langness VF, Herrera CM, Williams DA, Fong LK, Leestemaker Y, et al. Ldl cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-beta in iPSC-derived Alzheimer’s illness neurons. Cell Stem Cell. 2019;24:363–75.
Google Scholar
Gong Y, Klein Wolterink RGJ, Janssen I, Groot AJ, Bos GMJ, Germeraad WTV. Rosuvastatin enhances VSV-G lentiviral transduction of NK Cells by way of upregulation of the low-density lipoprotein receptor. Mol Ther Strategies Clin Dev. 2020;17:634–46.
Google Scholar
Schlitzer A, Sivakamasundari V, Chen J, Sumatoh HR, Schreuder J, Lum J, et al. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming on the widespread DC progenitor stage within the bone marrow. Nat Immunol. 2015;16:718–28.
Google Scholar
Noubade R, Majri-Morrison S, Tarbell KV. Past cDC1: Rising roles of DC crosstalk in most cancers immunity. Entrance Immunol. 2019;10:1014.
Google Scholar
Du Y, Broering R, Li X, Zhang X, Liu J, Yang D, et al. In vivo mouse fashions for hepatitis b virus an infection and their utility. Entrance Immunol. 2021;12:766534.
Google Scholar
Dai L, Zou L, Meng L, Qiang G, Yan M, Zhang Z. Ldl cholesterol metabolism in neurodegenerative ailments: molecular mechanisms and therapeutic targets. Mol Neurobiol. 2021;58:2183–201.
Google Scholar
Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, et al. Ldl cholesterol induces CD8(+) T cell exhaustion within the tumor microenvironment. Cell Metab. 2019;30:143–56 e145.
Google Scholar
Tall AR, Yvan-Charvet L. Ldl cholesterol, irritation and innate immunity. Nat Rev Immunol. 2015;15:104–16.
Google Scholar
Matsumoto M, Einhaus D, Gold ES, Aderem A. Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription elements. J Immunol. 2004;172:7377–84.
Google Scholar
Guo C, Chi Z, Jiang D, Xu T, Yu W, Wang Z, et al. Ldl cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 Inflammasome activation and ldl cholesterol biosynthetic signaling in macrophages. Immunity. 2018;49:842–56.
Google Scholar
Braga Filho JAF, Abreu AG, Rios CEP, Trovao LO, Silva DLF, Cysne DN, et al. Prophylactic therapy with simvastatin modulates the immune response and will increase animal survival following deadly sepsis an infection. Entrance Immunol. 2018;9:2137.
Google Scholar
Xia Y, Xie Y, Yu Z, Xiao H, Jiang G, Zhou X, et al. The mevalonate pathway is a druggable goal for vaccine adjuvant discovery. Cell. 2018;175:1059–73.
Google Scholar
Chang FM, Wang YP, Lang HC, Tsai CF, Hou MC, Lee FY, et al. Statins lower the danger of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based examine. Hepatology. 2017;66:896–907.
Google Scholar
Goh MJ, Sinn DH, Kim S, Woo SY, Cho H, Kang W, et al. Statin use and the danger of hepatocellular carcinoma in sufferers with power Hepatitis B. Hepatology. 2020;71:2023–32.
Google Scholar
Rao GA, Pandya PK. Statin remedy improves sustained virologic response amongst diabetic sufferers with power hepatitis C. Gastroenterology. 2011;140:144–52.
Google Scholar
Gorabi AM, Kiaie N, Bianconi V, Jamialahmadi T, Al-Rasadi Okay, Johnston TP, et al. Antiviral results of statins. Prog Lipid Res. 2020;79:101054.
Google Scholar
Shrivastava-Ranjan P, Flint M, Bergeron É, McElroy AK, Chatterjee P, Albariño CG, et al. Statins suppress Ebola virus infectivity by interfering with glycoprotein processing. mBio. 2018;9:e00660–18.
Google Scholar
Abdel-Latif RG, Mohammed S, Elgendy IY. Statin remedy and SAR-COV-2: an out there and potential remedy? Eur Coronary heart J Cardiovasc Pharmacother. 2020;6:333–4.
Google Scholar
Rai D, Pham NL, Harty JT, Badovinac VP. Monitoring the overall CD8 T cell response to an infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J Immunol. 2009;183:7672–81.
Google Scholar
Shih C, Chou SF, Yang CC, Huang JY, Choijilsuren G, Jhou RS. Management and eradication methods of Hepatitis B virus. Traits Microbiol. 2016;24:739–49.
Google Scholar
Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492–9.
Google Scholar
Cox MA, Nechanitzky R, Mak TW. Verify level inhibitors as therapies for infectious ailments. Curr Opin Immunol. 2017;48:61–7.
Google Scholar
Miller BC, Sen DR, Al Abosy R, Bi Okay, Virkud YV, LaFleur MW, et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor management and reply to checkpoint blockade. Nat Immunol. 2019;20:326–36.
Google Scholar
Wang X, Dong A, Xiao J, Zhou X, Mi H, Xu H, et al. Overcoming HBV immune tolerance to get rid of HBsAg-positive hepatocytes by way of pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice. Cell Mol Immunol. 2016;13:850–61.
Google Scholar
Zhao H, Han Q, Yang A, Wang Y, Wang G, Lin A, et al. CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance in opposition to HBV. Int J Biol Sci. 2022;18:154–65.
Google Scholar
Wahlström A, Sayin SI, Marschall HU, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its influence on host metabolism. Cell Metab. 2016;24:41–50.
Google Scholar
Hu J, Wang C, Huang X, Yi S, Pan S, Zhang Y, et al. Intestine microbiota-mediated secondary bile acids regulate dendritic cells to attenuate autoimmune uveitis by means of TGR5 signaling. Cell Rep. 2021;36:109726.
Google Scholar
Meng Z, Chen Y, Lu M. Advances in focusing on the innate and adaptive immune techniques to remedy power Hepatitis B Virus an infection. Entrance Immunol. 2019;10:3127.
Google Scholar
Thompson PD. What to consider and do about statin-associated hostile results. JAMA. 2016;316:1969–70.
Google Scholar
Gurevich VS, Shovman O, Slutzky L, Meroni PL, Shoenfeld Y. Statins and autoimmune ailments. Autoimmun Rev. 2005;4:123–9.
Google Scholar
Noël B. Autoimmune illness and different potential side-effects of statins. Lancet. 2004;363:2000.
Google Scholar
Moosmann B, Behl C. Selenoprotein synthesis and side-effects of statins. Lancet. 2004;363:892–4.
Google Scholar
